These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3922462)

  • 1. Practical results of treatment with disease-modifying antirheumatoid drugs.
    Thompson PW; Kirwan JR; Barnes CG
    Br J Rheumatol; 1985 May; 24(2):167-75. PubMed ID: 3922462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine.
    Dwosh IL; Stein HB; Urowitz MB; Smythe HA; Hunter T; Ogryzlo MA
    Arthritis Rheum; 1977 Mar; 20(2):685-92. PubMed ID: 403921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.
    Paulus HE; Egger MJ; Ward JR; Williams HJ
    Arthritis Rheum; 1990 Apr; 33(4):477-84. PubMed ID: 2109613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 10. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs.
    Kay EA; Pullar T
    Br J Rheumatol; 1992 Jul; 31(7):477-83. PubMed ID: 1352723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
    Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Gold revalued.
    Lancet; 1974 Apr; 1(7861):789-90. PubMed ID: 4132717
    [No Abstract]   [Full Text] [Related]  

  • 16. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs.
    Scherak O; Popp W; Kolarz G; Wottawa A; Ritschka L; Braun O
    J Rheumatol; 1993 Jun; 20(6):944-9. PubMed ID: 8102405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years.
    Sokka TM; Kaarela K; Möttönen TT; Hannonen PJ
    Clin Exp Rheumatol; 1999; 17(5):527-32. PubMed ID: 10544834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2009 Mar; 19(3):395-403. PubMed ID: 19252250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.